, ,
This post explains why protein matters so much during GLP1 therapy, how much you should aim for, and practical ways to meet your goals even on low-appetite days
People taking these drugs for obesity often describe a quieting of food noise, the persistent preoccupation with food that drives overeating, Al-Aly said
Third, human studies are highly specific to population, protocol, endpoint, duration, and monitoring design
Retatrutide vs Mounjaro: the big difference Here's the headline: Mounjaro = dual agonist (2 targets) Retatrutide = triple agonist (3 targets) So retatrutide has an "extra lever" (the glucagon receptor) on top of the GLP1 and GIP effects
The peptide has only mild side effects like redness and itching at the injection site